期刊文献+

胃间质瘤的手术治疗 被引量:11

Surgical Resection of Gastric Stromal Tumors
下载PDF
导出
摘要 目的探讨胃间质瘤的手术治疗方法及临床病理特点.方法回顾性分析经手术治疗的78例胃间质瘤患者的临床和病理资料,其中男34例,女44例.手术完全切除76例,其中胃楔形切除39例,远端胃大部切除术17例,近端胃大部切除术20例;姑息性切除2例.结果肿瘤平均直径5.5 cm,其中<5 cm者39例,5~10 cm者27例,>10 cm者12例.病变位于胃窦部12例,胃体部30例,胃底部36例.胃周淋巴结转移2例(2.6%).免疫组化结果:CD117阳性74例(94.9%),CD34阳性61例(78.2%),SMA阳性29例(37.2%),Desmin阳性8例(10.3%),S-100阳性8例(10.3%).72例(92.3%)获随访,平均56.1(3~168)个月,术后5年生存率为70.3%,术后复发转移11例(15.3%),术后复发转移者再次手术治疗6例,再次手术切除可延长患者生命.结论胃间质瘤的治疗以手术为主,术中应注意完整切除和防止肿瘤破裂. Objective To investigate the clinic pathological features and surgical access for gastric stromal tumor(GST). Methods Seventy eight cases of GST underwent surgical treatment were retrospectively reviewed in terms of clinical and pathological features. 34 male and 44 female were included, in which 76 cases underwent radical resection, including 39 cases of wedge resection, 17 cases of distal subtotal gastrectomy, and 20 cases of proximal subtotal gastrectomy. The rest 2 cases underwent palliative resection. Result Average diameter of tumor was 5.5 cm, including 39 cases less than 5 cm, 27 cases between 5 to 10 cm, 12 cases over 10 cm. The locations were gastric antrum in 12 cases, gastric body in 30 cases and gastric fundus in 36 cases. 2 cases had perigastric lymph note metastasis (2.6%). Immunohistochemistry staining showed CD117 positive in 74 cases(94.9%), CD34 positive in 61 cases(78.2%), SMA positive in 29 cases(37.2%), Desmin positive in 8 cases(10.3%), S-100 positive in 8 cases(10.36%). 5-year survival rate was 70.3% with 3 to 168 months(mean 56.1 months) follow-up in 72 cases. Recurrence occurred in 11 cases(15.3%), of which 6 cases underwent reoperation. Conclusion Resection remains the major treatment of GST, complete excision and prevention of tumor rupture should be focused on during the operation.
机构地区 中国医学科学院
出处 《中国现代手术学杂志》 2005年第3期183-185,共3页 Chinese Journal of Modern Operative Surgery
关键词 胃肿瘤 胃间质瘤 手术方法 病理学 GST 免疫组化 stomach neoplasms stromal tumors
  • 相关文献

参考文献9

  • 1朱雄增,侯英勇.对胃肠道间质瘤的再认识[J].中华病理学杂志,2004,33(1):3-5. 被引量:156
  • 2Mazur MT, Clark HB. Gastric stromal tumors: reappraisal of histogenesis[J]. Am J Surg Pathol, 1983,7(6) :507-519.
  • 3Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of e-kit in human gastrointestinal stromal tumors [ J]. Science, 1998,279(5350) :577-580.
  • 4Lozano MD, Rodriguez J, Algarra SM, et al. Fine-needle aspiration cytology and immunocytochemistry in the diagnosis of 24 gastrointestinal stromal tumors [ J ]. Diagn Cytopathol,2003,28 ( 3 ):131-135.
  • 5DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival[ J]. Ann Surg,2000,231 ( 1 ) :51-58.
  • 6Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST:emerging approaches to adjuvant and neoadjuvant therapy[ J ]. Ann Surg Oncol,2004,11 (5) :465-475.
  • 7Kwon SJ:Korean Gastric Cancer Study Group. Surgey and prognostic factors for gastric stromal tumor[J]. World J Surg, 2001,25(3) :290-295.
  • 8Trupiano JK, Stewart RE, Misick C, et al. Gastric stromal tumors:A clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors [ J ]. Am J Surg Pathol, 2002,26(6) :705-714.
  • 9Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors[J]. N Engl J Med,2002,347(7) :472-480.

二级参考文献3

共引文献155

同被引文献155

引证文献11

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部